0000000000869825

AUTHOR

Dan Smyth

showing 3 related works from this author

New rules on driver licensing for patients with obstructive sleep apnea: European Union Directive 2014/85/EU

2016

Editorial, no abstract

medicine.medical_specialtybusiness.industryMedicine (all)Cognitive NeuroscienceApplied psychologyAlternative medicineGeneral MedicineDriver licensingCognitive neuroscienceBehavioral neuroscienceDirectivemedicine.diseaseObstructive sleep apnea03 medical and health sciencesBehavioral Neuroscience0302 clinical medicine030228 respiratory systemMedicinemedia_common.cataloged_instanceEuropean unionbusiness030217 neurology & neurosurgerymedia_commonJournal of Sleep Research
researchProduct

New rules on driver licensing for patients with obstructive sleep apnoea: EU Directive 2014/85/EU.

2016

The widespread recognition that obstructive sleep apnoea (OSA) represents an important risk factor for motor vehicle accidents (MVA), which is reversed by successful therapy with continuous positive airway pressure (CPAP), has led to a revision of annex III of the European Union (EU) directive on driving licences that is subject to mandatory implementation by all member states from December 31, 2015 [1]. This directive was the result of recommendations from a working group established by the Transport and Mobility Directorate of the European Commission in 2012 [2]. The directive states [1] Joint ERS/ESRS working group on the EU directive on issuing driving licences in obstructive sleep apno…

Pulmonary and Respiratory MedicineAutomobile Drivingmedicine.medical_treatmentsleepinessSeverity of Illness Index03 medical and health sciences0302 clinical medicinemedia_common.cataloged_instanceMedicineHumansEuropean commissionOperations managementContinuous positive airway pressureEuropean UnionEuropean unionmedia_commonLicensureSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryMember statesAccidents TrafficDriver licensingDirectiverespiratory tract diseases030228 respiratory systemSleep (system call)businessLicensure030217 neurology & neurosurgery
researchProduct

European Respiratory Society statement on sleep apnoea, sleepiness and driving risk

2021

Obstructive sleep apnoea (OSA) is highly prevalent and is a recognised risk factor for motor vehicle accidents (MVA). Effective treatment with continuous positive airway pressure has been associated with a normalisation of this increased accident risk. Thus, many jurisdictions have introduced regulations restricting the ability of OSA patients from driving until effectively treated. However, uncertainty prevails regarding the relative importance of OSA severity determined by the apnoea–hypopnoea frequency per hour and the degree of sleepiness in determining accident risk. Furthermore, the identification of subjects at risk of OSA and/or accident risk remains elusive. The introduction of off…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAutomobile DrivingSleepinessmedia_common.quotation_subjectmedicine.medical_treatmentPoison controlSettore MED/10 - Malattie Dell'Apparato RespiratorioSleep ApnoeaSuicide preventionOccupational safety and healthDriving Simulators03 medical and health sciences0302 clinical medicineRisk FactorsEpidemiologyInjury preventionSleep Apnoea Driving Accident Risk Sleepiness Screening Driving Simulators Treatment RegulationsmedicineHumansContinuous positive airway pressureIntensive care medicineRegulationsmedia_commonSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryAccidents TrafficHuman factors and ergonomicsnervous system diseasesrespiratory tract diseasesTreatment030228 respiratory systemAccident RiskScreeningHuman medicinebusiness030217 neurology & neurosurgeryDrivingVigilance (psychology)
researchProduct